0001237899-13-000025.txt : 20130508 0001237899-13-000025.hdr.sgml : 20130508 20130508174909 ACCESSION NUMBER: 0001237899-13-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130506 FILED AS OF DATE: 20130508 DATE AS OF CHANGE: 20130508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YANCOPOULOS GEORGE CENTRAL INDEX KEY: 0001226690 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 13825841 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-05-06 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001226690 YANCOPOULOS GEORGE 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 1 0 0 President Regeneron Laboratori Common Stock 2013-05-06 4 M 0 192308.0 13.0 A 1309638 D Common Stock 2013-05-06 4 F 0 9599.0 260.44 D 1300039 D Common Stock 2013-05-06 4 F 0 93644.0 260.44 D 1206395 D Common Stock 2013-05-07 4 S 0 13457.0 261.66 D 1192938 D Common Stock 2013-05-07 4 S 0 47876.0 262.43 D 1145062 D Common Stock 2013-05-07 4 S 0 38267.0 263.22 D 1106795 D Common Stock 2013-05-07 4 S 0 400.0 264.21 D 1106395 D Common Stock 5591 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 13.0 2013-05-06 4 M 0 192308.0 D 2013-12-15 Common Stock 192308 0 D Non-Qualified Stock Option (right to buy) 260.44 2013-05-06 4 A 0 9599.0 A 2013-11-06 2013-12-15 Common Stock 9599 9599 D Represents volume-weighted average price of sales of 13,457 shares of Company stock on May 7, 2013 at prices ranging from $261.50 to $261.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2013 at each separate price. Represents volume-weighted average price of sales of 47,876 shares of Company stock on May 7, 2013 at prices ranging from $262.00 to $262.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2013 at each separate price. Represents volume-weighted average price of sales of 38,267 shares of Company stock on May 7, 2013 at prices ranging from $263.00 to $263.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2013 at each separate price. Represents volume-weighted average price of sales of 400 shares of Company stock on May 7, 2013 at prices ranging from $264.06 to $264.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2013 at each separate price. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. /s/**George D. Yancopoulos 2013-05-08